Retrospective Analysis of the Impact of Adalimumab Initiation on Corticosteroid Utilization and Medical Costs Among Biologic-Naïve Patients with Rheumatoid Arthritis
Crossref DOI link: https://doi.org/10.1007/s40744-019-00184-5
Published Online: 2019-11-18
Published Print: 2020-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Spivey, Christina A.
Winthrop, Kevin L.
Griffith, Jenny
Kaplan, Cameron M.
Qiao, Yanru
Postlethwaite, Arnold E.
Wang, Junling
Funding for this research was provided by:
AbbVie
Text and Data Mining valid from 2019-11-18
Version of Record valid from 2019-11-18
Article History
Received: 8 September 2019
First Online: 18 November 2019